Sansure Biotech Company Description
Sansure Biotech Inc. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments in China.
It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tract infections; nucleic acid tests and fluorescence diagnostic kits for blood-borne infections; RNA diagnostic kits for gastrointestinal infections; and diagnostic kits for monkeypox, epstein-barr virus, and human cytomegalovirus DNA, as well as rapid antigen tests.
The company provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems.
In addition, it engages in the research and development, production, and sale of drugs; procurement and sale of raw materials; manufacture of instruments; manufacture and sale of electronic equipment; trading; investment advisory; medical research and experimental development; and internet sales, as well as offers third-party medical testing and biotechnology development services.
The company was founded in 2008 and is headquartered in Changsha, China.
Country | China |
Founded | 2008 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 2,006 |
CEO | Lizhong Dai |
Contact Details
Address: No. 680, Lusong Road Changsha, 410205 China | |
Phone | 86 731 8888 3176 |
Website | sansure.com.cn |
Stock Details
Ticker Symbol | 688289 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE1000043J1 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Lizhong Dai | Chairman of the Board and GM |
Zhu Peng | Chief Financial Officer, Deputy GM and Director |
Peng Yin | Deputy GM, Chief Technology Officer and Senior Vice President |
Xialin Yu | Deputy GM and Director |
Xu Fan | Deputy GM and Director |
Jia Liu | Deputy GM and Director |
Jun Zhou | Deputy General Manager |
Kai Liu | Deputy General Manager |
Jian Zhu | Deputy General Manager |
Zhongping Deng | Deputy General Manager |